(Q43040921)

English

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

liver cirrhosis

0 references

end-stage liver disease

1 reference

based on heuristic

inferred from title

author name string

Edoardo Giannini

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Federica Botta

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Emanuela Testa

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Paola Romagnoli

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Simone Polegato

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Federica Malfatti

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Alessandra Fumagalli

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bruno Chiarbonello

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Domenico Risso

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Roberto Testa

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2855-2860

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

MELD: the end of Child-Pugh classification?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

The utility of AST/ALT ratio as a non-invasive demonstration of the degree of liver fibrosis in chronic HCV patients on long-term haemodialysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Liver biopsy in chronic hepatitis C: routine or selective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

To MELD or not to MELD?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07053.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2002.07053.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43040921&oldid=2099859116"